Complete or partial reduction of the Met receptor tyrosine kinase in distinct circuits differentially impacts mouse behavior

Journal of Neurodevelopmental Disorders

Volumn 7, Issue 1, 2015, Pages

  Thompson, Barbara L ^a,b   Levitt, Pat ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Autism; Behavior; Fear learning; Gene dose; Met; Mouse; Phenotype

Indexed keywords

NESTIN; SCATTER FACTOR RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN CORTEX; BRAIN DEVELOPMENT; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; EMOTIONAL DISORDER; EXPERIMENTAL BEHAVIORAL TEST; FEAR; HETEROZYGOSITY; HYPOACTIVITY; MALE; MAZE TEST; MOUSE; NERVE CELL; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOCIAL PROBLEM; T-MAZE TEST;

EID: 84945920332     PISSN: 18661947     EISSN: 18661955     Source Type: Journal    
DOI: 10.1186/s11689-015-9131-8     Document Type: Article

References (75)

1. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251(4995):802-4.
2. Graveel CR, Tolbert D, Vande Woude GF. MET: a critical player in tumorigenesis and therapeutic target. Cold Spring Harb Perspect Biol. 2013;5(7):a009209.
3. Judson MC, Eagleson KL, Wang L, Levitt P. Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain. J Comp Neurol. 2010;518(21):4463-78. doi: 10.1002/cne.22467.
4. Lim CS, Walikonis RS. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cell Signal. 2008;20(5):825-35. doi: 10.1016/j.cellsig.2007.12.013.
5. Tyndall SJ, Patel SJ, Walikonis RS. Hepatocyte growth factor-induced enhancement of dendritic branching is blocked by inhibitors of N-methyl-D-aspartate receptors and calcium/calmodulin-dependent kinases. J Neurosci Res. 2007;85(11):2343-51.
6. Qiu S, Aldinger KA, Levitt P. Modeling of autism genetic variations in mice: focusing on synaptic and microcircuit dysfunctions. Dev Neurosci. 2012;34(2-3):88-100.
7. Peng Y, Huentelman M, Smith C, Qiu S. MET receptor tyrosine kinase as an autism genetic risk factor, Bioinformatics of behavior: part 2. 1st ed. Philadelphia: Elsevier Inc; 2014. p. 135-65.
8. Qiu S, Lu Z, Levitt P. MET receptor tyrosine kinase controls dendritic complexity, spine morphogenesis, and glutamatergic synapse maturation in the hippocampus. J Neurosci. 2014;34(49):16166-79.
9. Eagleson KL, Milner TA, Xie Z, Levitt P. Synaptic and extrasynaptic location of the receptor tyrosine kinase met during postnatal development in the mouse neocortex and hippocampus. J Comp Neurol. 2013;521(14):3241-59. doi: 10.1002/cne.23343.
10. Judson MC, Amaral DG, Levitt P. Conserved subcortical and divergent cortical expression of proteins encoded by orthologs of the autism risk gene MET. Cereb Cortex. 2011;21(7):1613-26. doi: 10.1093/cercor/bhq223.
11. Judson MC, Bergman MY, Campbell DB, Eagleson KL, Levitt P. Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol. 2009;513(5):511-31. doi: 10.1002/cne.21969.
12. Eagleson KL, Campbell DB, Thompson BL, Bergman MY, Levitt P. The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res. 2010;4(1):68-83.
13. Mukamel Z, Konopka G, Wexler E, Osborn GE, Dong H, Bergman MY, et al. Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk. J Neurosci. 2011;31(32):11437-42. doi: 10.1523/JNEUROSCI.0181-11.2011.
14. Bernard A, Lubbers LS, Tanis KQ, Luo R, Podtelezhnikov AA, Finney EM, et al. Transcriptional architecture of the primate neocortex. Neuron. 2012;73(6):1083-99.
15. Qiu S, Anderson CT, Levitt P, Shepherd GM. Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase. J Neurosci. 2011;31(15):5855-64. doi: 10.1523/JNEUROSCI.6569-10.2011.
16. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res. 2008;1(3):159-68.
17. Jackson PB, Boccuto L, Skinner C, Collins JS, Neri G, Gurrieri F, et al. Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res. 2009;2(4):232-6.
18. Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, et al. Further evidence for the role of MET in autism susceptibility. Neurosci Res. 2010;68(2):137-41.
19. Abrahams BS, Arking DE, Campbell DB, Mefford HC, Morrow EM, Weiss LA, et al. SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs). Molecular Autism. 2013;4(1):1.
20. Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol. 2007;62(3):243-50. doi: 10.1002/ana.21180.
21. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A. 2006;103(45):16834-9. doi: 10.1073/pnas.0605296103.
22. Heuer L, Braunschweig D, Ashwood P, Van de Water J, Campbell DB. Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Translational Psychiatry. 2011;1(10):e48-7.
23. Lambert N, Wermenbol V, Pichon B, Acosta S, van den Ameele J, Perazzolo C, et al. A familial heterozygous null mutation of MET in autism spectrum disorder. Autism Res. 2014;7(5):617-22.
24. Campbell DB, Warren D, Sutcliffe JS, Lee EB, Levitt P. Association of MET with social and communication phenotypes in individuals with autism spectrum disorder. Am J Med Genet. 2009. doi: 10.1002/ajmg.b.30998.
25. Rudie JD, Hernandez LM, Brown JA, Beck-Pancer D, Colich NL, Gorrindo P, et al. Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron. 2012;75(5):904-15. doi: 10.1016/j.neuron.2012.07.010.
26. Hedrick A, Lee Y, Wallace GL, Greenstein D, Clasen L, Giedd JN, et al. Autism risk gene MET variation and cortical thickness in typically developing children and adolescents. Autism Res. 2012;5(6):434-9. doi: 10.1002/aur.1256.
27. Ey E, Leblond CS, Bourgeron T. Behavioral profiles of mouse models for autism spectrum disorders. Autism Res. 2011;4(1):5-16.
28. Crawley JN. Behavioral phenotyping strategies for mutant mice. Neuron. 2008;57(6):809-18.
29. Hamilton SM, Spencer CM, Harrison WR, Yuva-Paylor LA, Graham DF, Daza RAM, et al. Multiple autism-like behaviors in a novel transgenic mouse model. Behav Brain Res. 2011;218(1):29-41.
30. Ebens A, Brose K, Leonardo ED, Hanson MG, Bladt F, Birchmeier C, et al. Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron. 1996;17(6):1157-72.
31. Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JL, Jones KR. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci. 2002;22(15):6309-14.
32. Krysko O, Hulshagen L, Janssen A, Schütz G, Klein R, De Bruycker M, et al. Neocortical and cerebellar developmental abnormalities in conditions of selective elimination of peroxisomes from brain or from liver. J Neurosci Res. 2007;85(1):58-72.
33. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, Thorgeirsson SS. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A. 2004;101(13):4477-82.
34. Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 1999;835(1):18-26.
35. Tapp JT, Wehby JH, Ellis D. MOOSES: a multi-option observation system for experimental studies. Behav Res Methods, Instruments, Computers. 1995;27:25-31.
36. Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, Paylor R. Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl). 2009;204(2):361-73. doi: 10.1007/s00213-009-1466-y.
37. Hughes RN. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev. 2004;28(5):497-505. doi: 10.1016/j.neubiorev.2004.06.006.
38. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev. 2002;26(1):91-104.
39. Katz RJ, Chudler R. Y-maze behavior after an analog of ACTH 4-9, evidence for an attentional alteration. Psychopharmacology. 1980;71(1):95-6.
40. Kokkinidis L, Anisman H. Interaction between cholinergic and catecholaminergic agents in a spontaneous alternation task. Psychopharmacology. 1976;48(3):261-70.
41. Ueno K, Togashi H, Matsumoto M, Ohashi S, Saito H, Yoshioka M. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder. J Pharmacol Exp Ther. 2002;302(1):95-100.
42. Ueno KI, Togashi H, Mori K, Matsumoto M, Ohashi S, Hoshino A, et al. Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder. Behav Pharmacol. 2002;13(1):1-13.
43. Wall PM, Blanchard RJ, Markham C, Yang M, Blanchard DC. Infralimbic D1 receptor agonist effects on spontaneous novelty exploration and anxiety-like defensive responding in CD-1 mice. Behav Brain Res. 2004;152(1):67-79. doi: 10.1016/j.bbr.2003.09.035.
44. Wall PM, Blanchard RJ, Yang M, Blanchard DC. Infralimbic D2 receptor influences on anxiety-like behavior and active memory/attention in CD-1 mice. Prog Neuro-Psychopharmacol Biol Psychiatry. 2003;27(3):395-410. doi: 10.1016/S0278-5846(02)00356-1.
45. Thompson BL, Levitt P, Stanwood GD. Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Behav Brain Res. 2005;164(1):107-16.
46. Bielsky IF, Hu SB, Ren X, Terwilliger EF, Young LJ. The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study. Neuron. 2005;47(4):503-13. doi: 10.1016/j.neuron.2005.06.031.
47. Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT. Social amnesia in mice lacking the oxytocin gene. Nat Genet. 2000;25(3):284-8. doi: 10.1038/77040.
48. Ferkin MH, Li HZ. A battery of olfactory-based screens for phenotyping the social and sexual behaviors of mice. Physiol Behav. 2005;85(4):489-99. doi: 10.1016/j.physbeh.2005.05.014.
49. Moy SS, Nadler JJ, PEREZ A, Barbaro RP, Johns JM, Magnuson TR, et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 2004;3(5):287-302.
50. Gutierrez H, Dolcet X, Tolcos M, Davies A. HGF regulates the development of cortical pyramidal dendrites. Development. 2004;131(15):3717-26.
51. Maski KP, Jeste SS, Spence SJ. Common neurological co-morbidities in autism spectrum disorders. Curr Opin Pediatr. 2011;23(6):609-15. doi: 10.1097/MOP.0b013e32834c9282.
52. Bauman ML. Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics: J American Soc Experimental NeuroTherapeutics. 2010;7(3):320-7. doi: 10.1016/j.nurt.2010.06.001.
53. Croen LA, Zerbo O, Qian Y, Massolo ML, Rich S, Sidney S, et al. The health status of adults on the autism spectrum. Autism: Int Journal Res Pract. 2015. doi: 10.1177/1362361315577517.
54. Wohr M, Silverman JL, Scattoni ML, Turner SM, Harris MJ, Saxena R, et al. Developmental delays and reduced pup ultrasonic vocalizations but normal sociability in mice lacking the postsynaptic cell adhesion protein neuroligin2. Behav Brain Res. 2013;251:50-64. doi: 10.1016/j.bbr.2012.07.024.
55. Pagani JH, Williams Avram SK, Cui Z, Song J, Mezey E, Senerth JM, et al. Raphe serotonin neuron-specific oxytocin receptor knockout reduces aggression without affecting anxiety-like behavior in male mice only. Genes Brain Behav. 2015;14(2):167-76. doi: 10.1111/gbb.12202.
56. Mosienko V, Beis D, Alenina N, Wohr M. Reduced isolation-induced pup ultrasonic communication in mouse pups lacking brain serotonin. Molecular Autism. 2015;6:13. doi: 10.1186/s13229-015-0003-6.
57. Joeyen-Waldorf J, Edgar N, Sibille E. The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice. Brain Res. 2009;1286:84-93. doi: 10.1016/j.brainres.2009.06.079.
58. Bi W, Yan J, Shi X, Yuva-Paylor LA, Antalffy BA, Goldman A, et al. Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Hum Mol Genet. 2007;16(15):1802-13. doi: 10.1093/hmg/ddm128.
59. de Rezende VB, Rosa DV, Comim CM, Magno LA, Rodrigues AL, Vidigal P, et al. NCS-1 deficiency causes anxiety and depressive-like behavior with impaired non-aversive memory in mice. Physiol Behav. 2014;130:91-8. doi: 10.1016/j.physbeh.2014.03.005.
60. Bai J, Ramos RL, Ackman JB, Thomas AM, Lee RV, LoTurco JJ. RNAi reveals doublecortin is required for radial migration in rat neocortex. Nat Neurosci. 2003;6(12):1277-83. doi: 10.1038/nn1153.
61. Corbo JC, Deuel TA, Long JM, LaPorte P, Tsai E, Wynshaw-Boris A, et al. Doublecortin is required in mice for lamination of the hippocampus but not the neocortex. J Neurosci. 2002;22(17):7548-57.
62. Sorge RE, Martin LJ, Isbester KA, Sotocinal SG, Rosen S, Tuttle AH, et al. Olfactory exposure to males, including men, causes stress and related analgesia in rodents. Nat Methods. 2014;1-6.
63. Spencer CM, Alekseyenko O, Hamilton SM, Thomas AM, Serysheva E, Yuva-Paylor LA, et al. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res. 2011;4(1):40-56.
64. Jiang Y, Ehlers M. Modeling autism by SHANK gene mutations in mice. Neuron. 2013;78:8-27.
65. Diamond DM, Campbell AM, Park CR, Halonen J, Zoladz PR. The temporal dynamics model of emotional memory processing: a synthesis on the neurobiological basis of stress-induced amnesia, flashbulb and traumatic memories, and the Yerkes-Dodson law. Neural Plasticity. 2007;2007:60803. doi: 10.1155/2007/60803.
66. Halpin B. Effects of arousal level on olfactory sensitivity. Percept Mot Skills. 1978;46(3 Pt 2):1095-102. doi: 10.2466/pms.1978.46.3c.1095.
67. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A. 2003;100(10):6186-91. doi: 10.1073/pnas.0931309100.
68. Cools R, D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry. 2011;69(12):e113-25. doi: 10.1016/j.biopsych.2011.03.028.
69. Diamond DM, Bennett MC, Fleshner M, Rose GM. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus. 1992;2(4):421-30. doi: 10.1002/hipo.450020409.
70. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141(7):1117-34.
71. Berg JM, Geschwind DH. Autism genetics: searching for specificity and convergence. Genome Biol. 2012;13(7):247. doi: 10.1186/gb4034.
72. Levitt P, Campbell DB. The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest. 2009;119(4):747-54. doi: 10.1172/JCI37934.
73. Sheng L, Ding X, Ferguson M, McCallister M, Rhoades R, Maguire M, et al. Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase. MET Toxicological Sci. 2010;118(2):625-34.
74. Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB. Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology. 2014;25(1):44-7. doi: 10.1097/EDE.0000000000000030.
75. Wu HH, Levitt P. Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstem. Dev Neurosci. 2013;35(1):1-16. doi: 10.1159/000346367.